Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Form 8.3 FD TECHNOLOGIES PLC

27 May 2025 11:54

RNS Number : 2393K
Barclays PLC
27 May 2025
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

FD TECHNOLOGIES PLC

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

23 May 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing(if any)

Class of relevant security:

0.5p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

120,167

0.54%

215,931

0.98%

(2)

Cash-settled derivatives:

and/or controlled:

260,752

1.18%

107,908

0.49%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

380,919

1.72%

323,839

1.46%

(b)

Rights to subscribe for new securities (including directors and other executive

options)

Class of relevant security in relation to

which subscription right exists

Details, including nature of the rights

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

0.5p ordinary

Purchase

3,086

24.4275 GBP

0.5p ordinary

Purchase

2,320

24.5000 GBP

0.5p ordinary

Purchase

1,147

24.4413 GBP

0.5p ordinary

Purchase

788

24.4336 GBP

0.5p ordinary

Purchase

577

24.3500 GBP

0.5p ordinary

Purchase

513

24.3436 GBP

0.5p ordinary

Purchase

184

24.2627 GBP

0.5p ordinary

Purchase

176

24.2500 GBP

0.5p ordinary

Purchase

100

24.3997 GBP

0.5p ordinary

Purchase

96

24.4500 GBP

0.5p ordinary

Purchase

72

24.6000 GBP

0.5p ordinary

Purchase

47

24.3198 GBP

0.5p ordinary

Purchase

46

24.3000 GBP

0.5p ordinary

Purchase

32

24.3750 GBP

0.5p ordinary

Purchase

19

24.4000 GBP

0.5p ordinary

Sale

1,695

24.4925 GBP

0.5p ordinary

Sale

359

24.5000 GBP

0.5p ordinary

Sale

176

24.2500 GBP

0.5p ordinary

Sale

108

24.4018 GBP

0.5p ordinary

Sale

96

24.4500 GBP

0.5p ordinary

Sale

81

24.3500 GBP

0.5p ordinary

Sale

46

24.3000 GBP

0.5p ordinary

Sale

37

24.2750 GBP

0.5p ordinary

Sale

32

24.3750 GBP

0.5p ordinary

Sale

19

24.4000 GBP

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

0.5p ordinary

SWAP

Decreasing Short

211

24.4472 GBP

0.5p ordinary

SWAP

Increasing Long

13

24.2997 GBP

0.5p ordinary

SWAP

Increasing Long

72

24.4987 GBP

0.5p ordinary

SWAP

Increasing Long

1,582

24.5000 GBP

0.5p ordinary

SWAP

Decreasing Long

513

24.3436 GBP

0.5p ordinary

SWAP

Decreasing Long

515

24.3500 GBP

0.5p ordinary

SWAP

Decreasing Long

2,143

24.4224 GBP

0.5p ordinary

SWAP

Decreasing Long

2,335

24.4259 GBP

0.5p ordinary

SWAP

Decreasing Long

1,768

24.5000 GBP

0.5p ordinary

SWAP

Decreasing Long

220

24.5184 GBP

0.5p ordinary

CFD

Increasing Short

454

24.3774 GBP

0.5p ordinary

CFD

Increasing Short

258

24.4306 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

27 May 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETARMLTMTITMFA
Date   Source Headline
12th Oct 20207:00 amRNSNotice of Results
30th Sep 20204:27 pmRNSTotal Voting Rights
16th Sep 20207:00 amRNSDirectorate Change
2nd Sep 20203:54 pmRNSIssue of Equity
2nd Sep 20207:00 amRNSTotal Voting Rights
26th Aug 20208:46 amRNSIssue of Equity
20th Aug 20206:10 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSEuronext Growth Dublin Notice
31st Jul 202012:01 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20207:00 amRNSAppointment of Kx Chief Revenue Officer
14th Jul 20207:00 amRNSDirectorate Change
9th Jul 20207:00 amRNSShare Option Plan Awards
9th Jul 20207:00 amRNSEuronext Growth Dublin Notice
8th Jul 20204:07 pmRNSResult of AGM
8th Jul 20207:00 amRNSAGM Statement
7th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSSenior Executive Appointment
3rd Jul 202010:23 amRNSIssue of Equity
2nd Jul 20207:00 amRNSDirectorate Change
30th Jun 20202:35 pmRNSTotal Voting Rights
9th Jun 20208:00 amRNSEuronext Growth Dublin Notice
8th Jun 20204:30 pmRNSNotice of AGM
3rd Jun 20202:33 pmRNSIssue of Equity
1st Jun 202011:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSEuronext Growth Dublin Notice
22nd May 20205:59 pmRNSIssue of Equity - Correction
21st May 20204:19 pmRNSIssue of Equity
19th May 20207:00 amRNSGlobal partnership agreement
19th May 20207:00 amRNSFull year results for the year ended 29 Feb 2020
9th Apr 20207:00 amRNSTrading Statement
31st Mar 202010:06 amRNSTotal Voting Rights
12th Mar 20207:00 amRNSEuronext Growth Dublin Notice
6th Mar 202010:52 amRNSIssue of Equity
17th Feb 20207:00 amRNSMajor oilfield services contract win
31st Jan 202012:01 pmRNSTotal Voting Rights
30th Jan 20207:00 amRNSEuronext Growth Dublin Notice
24th Jan 20202:01 pmRNSIssue of Equity
15th Jan 20207:00 amRNSCEO appointment and Board changes
31st Dec 20199:58 amRNSTotal Voting Rights
17th Dec 20197:00 amRNSEuronext Growth Dublin Notice
12th Dec 20197:00 amRNSEuronext Growth Dublin Notice
11th Dec 20193:10 pmRNSIssue of Equity
11th Dec 20197:50 amRNSHolding(s) in Company
6th Dec 20193:10 pmRNSIssue of Equity
29th Nov 20194:46 pmRNSTotal Voting Rights
15th Nov 20197:00 amRNSEuronext Growth Dublin Notice
8th Nov 20192:32 pmRNSIssue of Equity
5th Nov 20197:00 amRNSInterim results for the six months ended 31.08.19
1st Nov 201910:15 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.